J&J Becomes the Newest Player in the LAA Market

The deal has the New Brunswick, NJ-based company doling out about $400 million to be in the crowded space, which is home to Boston Scientific’s Watchman; Abbott Laboratories’ Amplatzer, and Medtronic’s recently-launched Penditure LAA exclusion system.